TeraPore is answering the call for innovation in bioprocessing through the development of high-capacity, high-yield bioseparation solutions that are well-suited to the demanding and precise manufacturing requirements of advanced therapeutics and novel biologics. Our Intelligent Membrane™ platform is a leap forward from conventional separations technologies, providing targeted and uniform nanofiltration capabilities that are engineered to tackle the most difficult bioseparation challenges.
Running a Startup: Perspective of Two Women Founders and CEOs from Cornell
Date: April 2, 2021
Time: 11:00 am to 12:00 pm (EST)
Location: Virtual Meeting
Rachel Dorin, Ph.D., President and CEO, and Co-Founder, TeraPore will be a panelist for the Women Innovators Initiative (WI2). Rachel, along with another woman founder and CEOs from Cornell University will share their experiences lessons learned during the formation and growth of their venture.